EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma

Takahiro Iwamoto iD, Kazuhiro Ogi iD, Takafumi Nakagaki, Takashi Sasaya, Sho Miyamoto iD, Koyo Nishiyama, Kenta Sasaki iD, Shintaro Sugita, Yasushi Sasaki iD, Akihiro Miyazaki iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Takahiro Iwamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Receptor, Notch1, Mouth Neoplasms, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Notch1 , a tumor suppressor gene, is one of the most frequently mutated genes in head and neck squamous cell carcinoma (HNSCC). Therefore, it is clinically important to investigate the effects of Notch1 mutations on antitumor immunity in oral squamous cell carcinoma (OSCC), a subset of HNSCC.

Aims

This study investigated Notch1 mutations and the expression of immune‐related proteins. We also examined the influence of Notch1 mutations on the immune microenvironment using a public database. Methods and Results We examined the expression of Notch1–4 in OSCC cell lines using qPCR. After Notch1 knockdown, OSCC cell proliferation and migration were analyzed using CCK8 and wound healing assays, respectively. Localization of programmed cell death ligand 1 (PD‐L1) was assessed by western blot and flow cytometry, while PD‐L1 expression was evaluated by western blot. In the somatic mutation analysis of 47 OSCC patients, the relationship between tumor‐infiltrating CD8 + T cells and PD‐L1 expression was analyzed using immunohistochemical (IHC) staining. Furthermore, data from The Cancer Genome Atlas (TCGA) were analyzed using multiple online bioinformatics tools to compare the characteristics of Notch1 mutations in HNSCC. The expression of Notch1 varied depending on the OSCC cell line phenotype, and Notch1 mutation was significantly correlated with tumor growth but not with tumor infiltration. In Notch1 knockdown, PD‐L1 expression on the tumor cell surface increased, while cytoplasmic PD‐L1 expression decreased. Among the 47 OSCC patients analyzed, seven (14%) had Notch1 mutations. Of those, five patients (71%) exhibited high tumor‐infiltrating CD8 + T cells and Notch1 mutation. Online bioinformatics analysis using the xCell algorithm revealed that Notch1‐mutated tumors had significantly higher levels of naïve CD8 + T cells compared to Notch1 wild‐type tumors.

Conclusion

These findings highlight Notch1 mutation as a potential therapeutic target for immune recognition in OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Notch1Mouth NeoplasmsSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellHumansMutationTumor MicroenvironmentCell Line, TumorCell ProliferationB7-H1 AntigenLymphocytes, Tumor-InfiltratingCD8-Positive T-LymphocytesFemaleGene Expression Regulation, NeoplasticCell MovementMaleMiddle Aged

Stichwörter der Autor:innen

CD8+ T cellsNotch1 mutationimmunotherapyoral squamous cell carcinomaprogrammed cell deathtumor microenvironment

Substanzen

Receptor, Notch1NOTCH1 protein, humanB7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Biology Division, Department of Liberal Arts and Sciences, Center for Medical Education, Sapporo Medical University, Sapporo, Japan.

ORCID-Profile: Takahiro Iwamoto, Kazuhiro Ogi, Sho Miyamoto, Kenta Sasaki, Yasushi Sasaki, Akihiro Miyazaki

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Iwamoto, T., Ogi, K., Nakagaki, T., Sasaya, T., Miyamoto, S., Nishiyama, K., Sasaki, K., Sugita, S., Sasaki, Y., & Miyazaki, A. (2025). Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma. Cancer Reports. https://doi.org/10.1002/cnr2.70345

Vancouver

Iwamoto T, Ogi K, Nakagaki T, Sasaya T, Miyamoto S, Nishiyama K, et al. Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma. Cancer Reports. 2025. doi:10.1002/cnr2.70345

BibTeX
@article{Iwamoto2025,
  author = {Iwamoto, Takahiro and Ogi, Kazuhiro and Nakagaki, Takafumi and Sasaya, Takashi and Miyamoto, Sho and Nishiyama, Koyo and Sasaki, Kenta and Sugita, Shintaro and Sasaki, Yasushi and Miyazaki, Akihiro},
  title = {Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70345}
}
Kostenlos starten →